Annual Drug Patent Expirations for IGALMI
Igalmi is a drug marketed by Bioxcel and is included in one NDA. There is one patent protecting this drug.
This drug has twenty patent family members in twelve countries.
The generic ingredient in IGALMI is dexmedetomidine hydrochloride. Additional details are available on the dexmedetomidine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
